These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5656771)

  • 21. Drug industry trying to change FDA's slow but sure policy.
    Demkovich LE
    Natl J (Wash); 1979 Jul; 11(29):1211-5. PubMed ID: 10242491
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA in earnest.
    Nature; 1969 Jan; 221(5177):213. PubMed ID: 5818229
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives. GOP sets its sights on Food and Drug Administration.
    Barnett AA
    Faulkner Grays Med Health; 1995 Feb; 49(8):suppl 1-4. PubMed ID: 10139918
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

  • 25. The drug recall dilemma.
    Provost GP
    Am J Hosp Pharm; 1966 Oct; 23(10):541. PubMed ID: 5915775
    [No Abstract]   [Full Text] [Related]  

  • 26. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 27. Urgent--drug recall. How well does the system work?
    Small WE
    Am Pharm; 1980 Aug; NS20(8):17-9. PubMed ID: 7424773
    [No Abstract]   [Full Text] [Related]  

  • 28. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 29. On working together with FDA.
    Loftus BT
    J Parenter Drug Assoc; 1980; 34(1):1-3. PubMed ID: 6899852
    [No Abstract]   [Full Text] [Related]  

  • 30. Pediatric testing of prescription drugs: the Food and Drug Administration's carrot and stick for the pharmaceutical industry.
    Karst KR
    Am Univ Law Rev; 2000; 49():739-72. PubMed ID: 11067732
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation and use of drug master files in the pharmaceutical industry.
    Personeus GR; Ascione P
    J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835
    [No Abstract]   [Full Text] [Related]  

  • 32. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 33. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 34. Cooperation with government agencies.
    Etherington ED
    West Med Med J West; 1965 Nov; 6(11):319-21. PubMed ID: 5898514
    [No Abstract]   [Full Text] [Related]  

  • 35. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
    Fed Regist; 2000 May; 65(86):25639-41. PubMed ID: 11010689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 37. Keeping prescription drug advertising honest. FDA's watchful eye.
    Welsh JS
    Am Pharm; 1980 May; NS20(5):40-4. PubMed ID: 7395709
    [No Abstract]   [Full Text] [Related]  

  • 38. [The therapeutic nightmare].
    Olin GA; Göth E; Liljestrand A; Werkö L
    Lakartidningen; 1966 Mar; 63(9):847-57. PubMed ID: 5919966
    [No Abstract]   [Full Text] [Related]  

  • 39. What ails the FDA?
    Jenny-Avital ER
    N Engl J Med; 2005 Jun; 352(24):2554-5. PubMed ID: 15962407
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical costs and the drug industry.
    Schwartz H
    Med Times; 1981 Mar; 109(3):21s-24s, 28s. PubMed ID: 7207081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.